Low-fat dietary pattern and breast cancer mortality by metabolic syndrome components: a secondary analysis of the Women’s Health Initiative (WHI) randomised trial

[1]  R. Chlebowski,et al.  Single Hormone Receptor-Positive Breast Cancers Have Distinct Characteristics and Survival , 2020, Annals of Surgical Oncology.

[2]  J. Manson,et al.  Eating Pattern Response to a Low-Fat Diet Intervention and Cardiovascular Outcomes in Normotensive Women: The Women's Health Initiative , 2020, Current developments in nutrition.

[3]  Gang Li,et al.  Association between metabolic syndrome and prognosis of breast cancer: a meta-analysis of follow-up studies , 2020, Diabetology & Metabolic Syndrome.

[4]  J. Manson,et al.  Low-Fat Dietary Pattern among Postmenopausal Women Influences Long-Term Cancer, Cardiovascular Disease, and Diabetes Outcomes , 2019, The Journal of nutrition.

[5]  J. Manson,et al.  Association of Low-Fat Dietary Pattern With Breast Cancer Overall Survival: A Secondary Analysis of the Women’s Health Initiative Randomized Clinical Trial , 2018, JAMA oncology.

[6]  V. Champion,et al.  Associations of metabolic syndrome and C‐reactive protein with mortality from total cancer, obesity‐linked cancers and breast cancer among women in NHANES III , 2018, International journal of cancer.

[7]  J. Manson,et al.  Cardiometabolic risk factors and survival after breast cancer in the Women's Health Initiative , 2018, Cancer.

[8]  P. Goodwin,et al.  Metabolic factors, anthropometric measures, diet, and physical activity in long-term breast cancer survivors: change from diagnosis and comparison to non-breast cancer controls , 2017, Breast Cancer Research and Treatment.

[9]  L. Kuller,et al.  A Randomized Trial of a Low-Fat Diet Intervention on Blood Pressure and Hypertension: Tertiary Analysis of the WHI Dietary Modification Trial. , 2016, American journal of hypertension.

[10]  L. Bernstein,et al.  An observational study to examine changes in metabolic syndrome components in patients with breast cancer receiving neoadjuvant or adjuvant chemotherapy , 2016, Cancer.

[11]  T. Hartley,et al.  Metabolic Syndrome Is Associated with Increased Breast Cancer Risk: A Systematic Review with Meta-Analysis , 2014, International journal of breast cancer.

[12]  A. Thompson,et al.  Progesterone receptor expression is an independent prognostic variable in early breast cancer: a population-based study , 2013, British Journal of Cancer.

[13]  F. Shirani,et al.  Effects of Dietary Approaches to Stop Hypertension (DASH) diet on some risk for developing type 2 diabetes: a systematic review and meta-analysis on controlled clinical trials. , 2013, Nutrition.

[14]  T. Rohan,et al.  A low-fat dietary pattern and risk of metabolic syndrome in postmenopausal women: the Women's Health Initiative. , 2012, Metabolism: clinical and experimental.

[15]  R. Krauss.  Low-Fat Dietary Pattern and Risk of Invasive Breast Cancer: The Women's Health Initiative Randomized Controlled Dietary Modification Trial , 2006, Current atherosclerosis reports.

[16]  L. Ford,et al.  Tamoxifen for the prevention of breast cancer: current status of the National Surgical Adjuvant Breast and Bowel Project P-1 study. , 2005, Journal of the National Cancer Institute.

[17]  Gordon H Guyatt,et al.  Randomized trials stopped early for benefit: a systematic review. , 2005, JAMA.

[18]  W. Willett,et al.  Test of the National Death Index. , 1984, American journal of epidemiology.